Table 2.
The clinical results of patients in three groups.
| NV group (n = 31) | OV group (n = 21) | TV group (n = 60) | p value | |
|---|---|---|---|---|
| Contact history | 0.43 | |||
| Direct contact | 28 (90) | 19 (91) | 49 (82) | |
| Indirect contact | 3 (10) | 2 (10) | 11 (18) | |
| Clustered feature | 25 (81) | 16 (76) | 42 (70) | 0.54 |
| CT positive | 21 (68) | 14 (67) | 30 (50) | 0.25 |
| Classification | 0.91 | |||
| Mild | 9 (29) | 7 (33) | 20 (33) | |
| Common | 22 (71) | 14 (67) | 40 (67) | |
| Severe/critical | 0 (0) | 0 (0) | 0 (0) | |
| Cycle threshold | 28.4 ± 5.7 | 29.4 ± 5.4 | 32.4 ± 5.1 | <0.01 |
| Time to peak (d) | 4.8 ± 2.8 | 4.8 ± 2.9 | 3.5 ± 2.3 | 0.03 |
| Antibody value | ||||
| IgG (S/CO) | 2.4 ± 3.2 | 4.7 ± 3.9 | 7.2 ± 3.3 | <0.001 |
| Ig M (S/CO) | 3.2 ± 9.6 | 4.1 ± 13.9 | 7.6 ± 18.1 | 0.39 |
| CRP positive | 8 (26) | 7 (33) | 17 (28) | 0.84 |
Data are presented as n (%) or mean ± standard deviation. NV: non-vaccines; OV: one-vacine; TV: two-vaccine; CRP: C reactive protein. p value, comparison among groups.